HLTH 2026 Recap: Key Takeaways for Healthcare Leaders

HLTH USA has never been a quiet conference, and the 2026 edition in Las Vegas did not try to be. The sensory baseline was high from the first evening: The week opened with a Welcome Reception at Zouk Nightclub, the show floor guided-breathing Relax Stations, there were ping-pong tables and live on-site blood draws. 

Underneath the lights, the conversation had changed. As expected, the sessions that filled the rooms were about who integrates AI, who reimburses it and who carries the legal liability when something goes wrong. Talks about weight-loss drugs turned to a steep drop-off after the first year. Wearables and AI agents kept returning to the same unglamorous problem: the data underneath.

Across four days of keynotes, an Oxford-style debate and show floor demos, one line from a presentation slide summed up the mood better than any keynote: "Access is easy to buy; engagement has to be designed."

Here are the themes that drove this year's biggest healthcare event: HLTH 2026.

Table of Contents

  1. AI Grows Up: From Chatbots to Governance
  2. Beyond the Prescription: What GLP-1 Care Needs to achieve adherence
  3. Phelps, Aoki, Meg Crane and De-Extinction: The Moments That Cut Through
  4. The Continuous Front Door: Wearables and Early Triage
  5. The Hard Infrastructure Reality: Missing Data and the EHR Question
  6. The Verdict: Governance, Front Doors and Ecosystems
  7. Final Thoughts on HLTH 2026: Proof Over Promises

1. AI Grows Up: From Chatbots to Governance

Monday's operational sessions moved past passive chatbots. The focus was autonomous agents handling prior authorization, denial management, revenue cycle management (RCM) and touchless billing, the back-office work that sits between a clinical decision and a paid claim.

Builders had their own room. Anthropic's healthcare team ran a workshop, Build with Anthropic's Healthcare Team, on developing clinical applications with its models. At the Nursing & Clinicians Breakfast, the SONSIEL and DAISY Nursing Innovation Awards, sponsored by Johnson & Johnson, put bedside, nurse-led innovation on the program.

The tension of the week landed in the Oxford-style debate "Human in the Loop or Human in the Way?", which asked in its title what many buyers are weighing. A panel theme pushed the same question from another angle, urging the industry to pivot from "AI built for productivity and profit to AI built for human thriving."

Picture courtesy of HLTH

Clinicians described a second front as care is reshaped. Patients now arrive with AI first, carrying self-generated symptom analyses and differential diagnoses. Providers manage a tech-assisted dialogue before the exam begins.

By Wednesday, attendees agreed that AI value was concentrated in three places: less time spent charting, faster access to what is already in the record and fewer manual handoffs between siloed systems.

Elsevier physician executive Dr. Claudine Lott added the evidence angle, presenting on anchoring clinical AI in peer-reviewed medical literature to prevent hallucinations and give diagnostics a reliable context.

The final signal on AI was plain: discussions had moved from technical feasibility to clinical integration, financial reimbursement and legal liability.

2. Beyond the Prescription: What GLP-1 Care Needs to achieve adherence

Few clinical topics took up as much room as GLP-1s. Sessions such as Beyond Weight Loss: Building Obesity Care That Lasts, Supply, Demand, and GLP-1s and The Case of Compounding examined the drop-off cliff, compounding pharmacy alternatives and the divide between employer coverage and out-of-pocket cash pay.

The numbers on stage explained the urgency:

  • The adherence drop-off. Roughly 55% of patients discontinue GLP-1s within a year.
  • The coverage cliff. U.S. employer coverage for weight-loss medications fell from 49% to 41% because of high costs, which is why the Tuesday session called it a "fire drill."
  • The access divide. Employer coverage on one side, compounding and cash pay on the other.
Picture courtesy of HLTH

The takeaway that traveled across the tracks was that a prescription is not a care strategy. Speakers described the temporary reduction in "food noise" as a behavioral window, and they urged using it to establish permanent lifestyle and dietary habits. Sustainable metabolic care needs wraparound nutrition, habit coaching and lifestyle medicine, and by Wednesday the consensus had settled on companion coaching, muscle preservation and lifestyle habits that carry outcomes past the end of the GLP-1 medication.

3. Phelps, Aoki, Meg Crane and De-Extinction: The Moments That Cut Through

Between sessions on unit economics and denial management, HLTH 2026 delivered a handful of human moments.

On opening day, HLTH's Jody Tropeano led a main-stage tribute to Meg Crane, the inventor who designed the first at-home pregnancy test. It celebrated a woman who helped put diagnostic autonomy in consumers' hands, which is a thread that ran through the entire week.

Michael Phelps later joined WHOOP CEO Will Ahmed for a conversation on mental wellness. Biometric data builds awareness, they agreed, but therapy, human connection and peer "buddy systems" are what sustain it.

Brain health and biotech shared the stage as well. Electronic music producer Steve Aoki spoke about his investments and advocacy in neuro-preservation, regenerative medicine and cognitive longevity, and Colossal Biosciences CEO Ben Lamm discussed de-extinction science and how multiplex genome editing translates to human healthcare technologies.

4. The Continuous Front Door: Wearables and Early Triage

Consumer biometrics are claiming a place as clinically recognized early-warning systems. Leaders from WHOOP, Nanit, Wheel and Flagship Pioneering discussed turning continuous biometric feeds into proactive clinical triage. WHOOP Chief Medical Officer Dr. Ami Bhatt said it directly:

"Wearables are going to show us signs of disease even before we have symptoms."

The week's announcements and showcases backed it up. Selected as the winner of the Making Aging Easier Pitch Challenge from the AgeTech Collaborative™ from AARP, startup Sensifai Health presented a wearable that detects immune and inflammatory activity before physical symptoms arise, reporting 90% sensitivity in predicting acute systemic inflammation, from a controlled study of 55 healthy adults, without blood draws.

Picture courtesy of HLTH

Noom announced the Noom Band, expanding into behavior-change hardware, and ŌURA highlighted its announced acquisition of Counsel Health to connect continuous ring biometrics directly with asynchronous clinical care teams.

The care between visits got attention too. On the Ferrari Stage, preventive cardiologist Dr. Danielle Belardo and MyFitnessPal CEO Mike Fisher discussed daily nutrient tracking as a way to connect lifestyle cardiology across the months between check-ups.

Point-of-care prevention is ready as well. Autonomous, one-minute AI diabetic retinal exams can help prevent vision loss among the 40+ million Americans with diabetes, provided health systems integrate them directly into standard visits.

5. The Hard Infrastructure Reality: Missing Data and the EHR Question

The STAT @ HLTH track, "A Dose of Reality on EHRs and AI," was led by STAT reporters Dr. Brittany Trang and Mario Aguilar with Dr. Ami Bhatt of WHOOP and Dr. Haider Warraich of ARPA-H. The panel asked whether ambient AI scribes solve clinical documentation or simply act as a patch over outdated legacy EHR architecture, and how to bring longitudinal, patient-generated data into clinical workflows without overwhelming providers.

Sunday's panel Trust Starts with Data: Building the Foundation for AI in Healthcare had already set up the argument. Computational power cannot compensate for missing, fragmented or dirty ground-truth patient records. Interoperability experts gave the problem a name, the "Seven Flavors of Nulls," and warned that autonomous AI agents will stumble over missing records unless health systems standardize semantic data rails.

6. The Verdict: Governance, Front Doors and Ecosystems

Registration closed at noon on Wednesday, luggage check wrapped up at 12:30 PM, and the AI Zone ran its last guided tours through AI Theater C for enterprise buyers evaluating implementations. The signals from the week were consistent:

  1. AI matured to governance. The questions became integration, reimbursement and liability.
  2. Wearables became the front door. Rings, bands and watches are solidifying as early-warning detection systems.
  3. GLP-1s require holistic ecosystems. Coaching, muscle preservation and lifestyle habits decide what happens after the medication ends.

Under all three sits the same dependency. The agents, the biometric feeds and the coaching programs all need records that are complete enough to act on, and engagement that was designed, not just purchased.

Final Thoughts on HLTH 2026: Proof Over Promises

Another great year has gone by. We all had a great time at HLTH. Four days, one show floor, and one undeniable truth: the next chapter of healthcare will be judged by what it can prove, not by what it can promise.

A big word that sums this year up is Governance and ROI. It is what turns a promising tool into something a clinician, a payer and a patient can rely on.

At its core, healthcare is about people. People who ask the hard questions before they sign. People who keep a human in the picture.

We left Las Vegas with a sharper focus on improving lives through digital health, and on building products that hold up long after the conference is over. It also reinforced the importance of asking our clients the right questions to help shape products that improve care quality, operational efficiency, and health outcomes.

Until next year!